An overview of recent developments in the treatment of heart failure: update from the ESC Congress 2013
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An overview of recent developments in the treatment of heart failure: update from the ESC Congress 2013
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 4, Pages 573-578
Publisher
Informa Healthcare
Online
2014-02-04
DOI
10.1517/13543784.2014.881799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
- (2013) EUROPEAN HEART JOURNAL
- Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
- (2013) Aldo P. Maggioni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction†
- (2013) Mihai Gheorghiade et al. EUROPEAN JOURNAL OF HEART FAILURE
- EURObservationalResearch Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
- (2013) Aldo P. Maggioni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure
- (2013) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
- (2013) Karl Swedberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
- (2013) Frank Ruschitzka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure†
- (2012) Erland Erdmann et al. EUROPEAN HEART JOURNAL
- Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes
- (2012) Mihai Gheorghiade et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Rationale and Design of CARRESS-HF, for the Heart Failure Clinical Research Network
- (2012) Bradley A. Bart et al. JOURNAL OF CARDIAC FAILURE
- Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program
- (2012) Marco Metra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
- (2012) John R Teerlink et al. LANCET
- Maternal vasodilation in pregnancy: the emerging role of relaxin
- (2011) Kirk P. Conrad AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
- (2011) John GF Cleland et al. LANCET
- Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
- (2011) F. I. Malik et al. SCIENCE
- Urocortins in heart failure
- (2010) Sowmya Venkatasubramanian et al. BIOCHEMICAL PHARMACOLOGY
- Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
- (2009) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started